Insider Monkey77d agoneutral
Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3125last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Barrons.com96d agoneutral
Gilead Posts a Loss on Acquisitions but Revenue Tells a Bigger StoryInsider Monkey167d agoneutral
Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology PortfolioSimply Wall St.183d agoneutral
Stronger HIV Pipeline And Acquisition Charges Might Change The Case For Investing In Gilead Sciences (GILD)